A false positive newborn screening result due to a complex allele carrying two frequent CF-causing variants

被引:16
作者
Bergougnoux, Anne [1 ]
Boureau-Wirth, Amandine [3 ]
Rouzier, Cecile [3 ]
Altieri, Jean-Pierre [1 ]
Verneau, Fanny [1 ]
Larrieu, Lise [1 ]
Koenig, Michel [1 ,2 ]
Claustres, Mireille [1 ,2 ]
Raynal, Caroline [1 ,2 ]
机构
[1] CHRU Montpellier, Lab Genet Mol, F-34093 Montpellier 5, France
[2] Univ Montpellier, Lab Genet Malad Rares, Inst Univ Rech Clin, EA 7402, F-34000 Montpellier 5, France
[3] Hop Archet 2, Serv Genet Med, F-06200 Nice, France
关键词
Cystic fibrosis; CFTR gene; Newborn screening; Complex allele; False positive; CYSTIC-FIBROSIS; DE-NOVO; VAS-DEFERENS; MUTATION; PATIENT; GENE; DIAGNOSIS; DELETION; ABSENCE; FRANCE;
D O I
10.1016/j.jcf.2016.04.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The detection of two frequent CFTR disease-causing variations in the context of a newborn screening program (NBS) usually leads to the diagnosis of cystic fibrosis (CF) and a relevant genetic counseling in the family. In the present study, CF-causing variants p.Phe508del (F508del) and c.3140-26 A > G (3272-26 A > G) were identified on a neonate with positive ImmunoReactive Trypsinogen test by the Elucigene (TM) CF30 kit. The CF diagnosis initially suggested, despite three inconclusive Sweat Chloride Tests (SCT), was finally ruled out after the familial segregation study combined with a negative SCT. Haplotype studies, based on the comparison of 80 p.Phe508del haplotypes, suggested a probable de novo occurrence of c.3140-26 A > G on the p.Phe508del ancestral allele in this family. This false positive case emphasizes the importance of SCT in the NBS strategy. Moreover, it raises the need for familial segregation studies in CF and in overall molecular diagnosis strategy of autosomal recessive diseases. (C) 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:309 / 312
页数:4
相关论文
共 22 条
[1]   Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy [J].
Audrezet, Marie Pierre ;
Munck, Anne ;
Scotet, Virginie ;
Claustres, Mireille ;
Roussey, Michel ;
Delmas, Dominique ;
Ferec, Claude ;
Desgeorges, Marie .
GENETICS IN MEDICINE, 2015, 17 (02) :108-116
[2]   Comprehensive and rapid genotyping of mutations and haplotypes in congenital bilateral absence of the vas deferens and other cystic fibrosis transmembrane conductance regulator-related disorders [J].
Bareil, Corinne ;
Guittard, Caroline ;
Altieri, Jean-Pierre ;
Templin, Carine ;
Claustres, Mireille ;
des Georges, Marie .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05) :582-588
[3]  
Bonini J, 2015, GENET MED
[4]   Newborn screening for cystic fibrosis: An opportunity to improve care and outcomes [J].
Campbell, PW ;
White, TB .
JOURNAL OF PEDIATRICS, 2005, 147 (03) :S2-S5
[5]  
Casals T, 1998, HUM MUTAT, pS99
[6]   European best practice guidelines for cystic fibrosis neonatal screening [J].
Castellani, Carlo ;
Southern, Kevin W. ;
Brownlee, Keith ;
Roelse, Jeannette Dankert ;
Duff, Alistair ;
Farrell, Michael ;
Mehta, Anil ;
Munck, Anne ;
Pollitt, Rodney ;
Sermet-Gaudelus, Isabelle ;
Wilcken, Bridget ;
Ballmann, Manfred ;
Corbetta, Carlo ;
de Monestrol, Isabelle ;
Farrell, Philip ;
Feilcke, Maria ;
Ferec, Claude ;
Gartner, Silvia ;
Gaskin, Kevin ;
Hammermann, Jutta ;
Kashirskaya, Nataliya ;
Loeber, Gerard ;
Macek, Milan, Jr. ;
Mehta, Gita ;
Reiman, Andreas ;
Rizzotti, Paolo ;
Sammon, Alec ;
Sands, Dorota ;
Smyth, Alan ;
Sommerburg, Olaf ;
Torresani, Toni ;
Travert, Georges ;
Vernooij, Annette ;
Elborn, Stuart .
JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (03) :153-173
[7]  
Claustres M, 2000, HUM MUTAT, V16, P143, DOI 10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO
[8]  
2-J
[9]   CFTR haplotypic variability for normal and mutant genes in cystic fibrosis families from southern France [J].
Claustres, M ;
Desgeorges, M ;
Moine, P ;
Morral, N ;
Estivill, X .
HUMAN GENETICS, 1996, 98 (03) :336-344
[10]   Detection of a de novo R1066H mutation in an Italian patient affected by cystic fibrosis [J].
Cremonesi, L ;
Cainarca, S ;
Rossi, A ;
Padoan, R ;
Ferrari, M .
HUMAN GENETICS, 1996, 98 (01) :119-121